Items where authors include "Poretta, Tayla"

Article

Brodtkorb, Thor Henrik, Knight, Christopher, Kamgar, Farzam et al. (6 more authors) (2024) Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence:a US payer perspective. Journal of Medical Economics. pp. 543-553. ISSN 941-837X

Teitsson, Siguroli, Brodtkorb, Thor Henrik, Kurt, Murat et al. (5 more authors) (2024) Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma:with a spotlight on nivolumab versus placebo. Journal of Medical Economics. pp. 473-481. ISSN 941-837X